Prof Claire Hogg is Professor of Practice in Paediatric Respiratory Medicine at Imperial College London and Clinical Director in Respiratory Paediatrics at Royal Brompton Hospital. She is clinical lead for the National Primary Ciliary Dyskinesia (PCD) Diagnostic service, in London.

Prof Hogg is a leader in clinical research in PCD and novel diagnostics. Many new techniques, including 3-dimensional electron tomography and the validation of immunofluorescence for the diagnosis of PCD, have been developed in her research group and under her supervision.

Her group is the first in the world to introduce the use of Artificial Intelligence to assist the diagnosis of PCD. She has had successive NIHR i4i grant funding to support this work. Her expertise extends to leading clinical trials: as the UK lead for the first clinical trial in PCD as part of an EU programme grant [BESTcilia: FP-7], and as Lead for the biomarker project for the first mRNA therapy trial in PCD [ReCode Therapeutics 2025]. She was lead for the BEAT-PCD Training School [COST Action, 2015-2019] and is Chair of the BEAT-PCD consortium “PCD bioresources”” work-package, aiming to develop an international PCD bioresource which can be used for testing novel PCD specific therapies.

Prof Hogg has also supervised many higher degrees [MD(Res) and PhD’s], MSc and BSc students to successful completion of projects, writing of dissertations, publications, and presentations.